Skip to main content

Change location

You are currently on the Canada (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Canada (English)
  • Careers
  • Media and News
  • Get in touch
    • Canada (English)
    • We are Bracco
    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
    • Product overview
      • X-ray/CT
      • Contrast agents

        • Gastrografin
        • ISOVUE
      • Medical devices

        • Protoco2l Touch
        • CT Exprès 3D
        • EmpowerCTA+
      • Fluoroscopy
        • E-Z-HD
        • E-Z-PAQUE
        • Liquid POLIBAR PLUS
        • Varibar
      • MRI
      • Contrast agents

        • MultiHance
        • ProHance
      • Medical Devices

        • EmpowerMR
      • CEUS
      • Contrast agents

        • SonoVue
      • Molecular imaging
      • Contrast agents

        • Choletec
        • Kinevac
      • Cardiovascular
      • Contrast agents

        • ISOVUE
      • Medical devices

        • ACIST CVi
        • ACIST RXi
    • Digital health
    • Oncology
    • Cardiology
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
    • Education
    • Next-Gen Projects
    • Our Partnerships
  • Events
    • Sustainability
    • Sustainability report
  • Our Stories
  1. Home
  2. Our Portfolio
  3. X-ray/CT
  4. Contrast agents

  5. Gastrografin

Gastrografin®

 

(diatrizoate meglumine and diatrizoate sodium solution USP)

Gastrografin® (diatrizoate meglumine and diatrizoate sodium solution USP) is a palatable lemon-flavored, water-soluble iodinated radiopaque contrast medium for oral or rectal administration used for radiographic examination of segments of the gastrointestinal tract, particularly in cases in which barium examinations would be potentially risky. Gastrografin is also used for examinations for foreign bodies on the pharynx and esophagus and disorders of the swallowing mechanism.

No literature available.

Please consult product monograph on Health Canada website:

 

https://pdf.hres.ca/dpd_pm/00065640.PDF

 

ProductProduct SKUInternal CodeDescription
Gastrografin
Diatrizoate Meglumine 66% and Diatrizoate Sodium 10%
4453070190324x30 mL bottles
4453270190412x120 mL bottles

 

 

PRODUCTS & SERVICES 

 

If you have any questions regarding any Bracco Imaging products or require Service and Support for our equipment.

 

[email protected] 

PROFESSIONAL SERVICES

 

The Professional Services Group is available to assist health care professionals with requests for scientific or medical information about Bracco Imaging products.

 

[email protected]

CUSTOMER SERVICE/ORDER DESK

 

If you need to place an order:

 

[email protected]/[email protected]

Contact us


Please fill out the form below and we will get back to you.

Different countries may have specific processes in place to handle reports of adverse reactions. To report an adverse reaction related to Bracco products, you can find specific contacts and information selecting the page "Pharmacovigilance" of your country.

I have read and understood the Bracco Privacy Notice regarding the processing of my personal data

I would like to receive communications from Bracco (via email and phone) including invitations to events, educational content, product updates, and information about Bracco services and initiatives. These communications may involve tools to measure engagement and interactions with Bracco’s initiatives.

I consent Bracco Imaging S.p.A. to analyze my professional interests and preferences to personalize communications, scientific updates, educational content, and event invitations, so that the information I receive is more relevant to my professional needs and activities.

Bracco Imaging France traite vos données personnelles aux fins de répondre à votre demande, telle que soumise via le formulaire ci-dessus.

Le traitement de vos données est basé sur l’intérêt légitime de Bracco (en termes d’organisation et de gestion des communications avec les tiers). Les intérêts légitimes poursuivis par Bracco sont mis en balance avec vos intérêts, libertés et droits fondamentaux qui exigent une protection de vos données personnelles. Les intérêts de Bracco ne peuvent prévaloir par rapport aux vôtres.

Tous les champs sont obligatoires. La non-fourniture de vos données peut empêcher la soumission de votre demande, allonger les délais de réponse et/ou empêcher une réponse.

Vos données sont accessibles à Bracco Imaging SpA (maison mère basée en Europe), ainsi qu’aux prestataires (basés en France ou en Europe) en charge de l’hébergement, la gestion et la maintenance du site internet Bracco et de l’outil de gestion de la relation client (outil CRM servant à suivre et traiter les demandes soumises via le formulaire ci-dessus).

Selon l’objet de votre demande, vos données seront transmises au(x) département(s) de Bracco Imaging France en mesure d’y répondre. Le cas échéant, nous vous informerons précisément comment ce(s) département(s) traite(nt) vos données personnelles aux fins de gérer votre demande.

Vos données seront conservées pendant un délai de 18 mois à compter de leur collecte par Bracco. Vous pouvez accéder à vos données, demander leur rectification ou leur effacement, ainsi que demander la limitation de leur traitement. Vous pouvez vous opposer au traitement pour des raisons tenant à votre situation particulière. Vous pouvez exercer vos droits ou demander des précisions relatives à la mise en balance entre les intérêts légitimes poursuivis par Bracco et les vôtres auprès du délégué à la protection des données (DPO): [email protected].

La gestion des notifications d’effets indésirables ou situations particulières de pharmacovigilance diffère d’un pays à l’autre. Pour rapporter un effet indésirable ou une situation particulière, veuillez consulter la page Pharmacovigilance de notre site internet.

Indications and Usage:

GASTROGRAFIN® (diatrizoate meglumine and diatrizoate sodium solution) is indicated for radiographic examination of the gastrointestinal tract, particularly in cases in which barium suspensions would be potentially risky as well as examinations for foreign bodies in the pharynx and esophagus and disorders of the swallowing mechanism. 

 

For additional information, please consult product monograph on Health Canada website: 

https://pdf.hres.ca/dpd_pm/00065640.PDF

 

IMPORTANT SAFETY INFORMATION:

Not for parenteral use; do not inject.  For oral or rectal administration only.  It should be kept in mind that serious or anaphylactoid reactions that may occur with intravascular administration of radiopaque contrast agents and are theoretically possible following administration by other routes.  Patients at increased risk include those with a history of a previous reaction to a contrast medium, patients with a known sensitivity to iodine per se, and patients with a known clinical hypersensitivity (bronchial asthma, hay fever and food allergies).

Please login to DocCheck
to view our products

Register here Forgot your password?

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182